, future trends, potential challenges & opportunities, and unmet medical needs You act as the key contact person for allocated... sciences, ideally as a medical doctor or pharmacist You have a minimum of 5-7 years of experience in product and/or portfolio...
, future trends, potential challenges & opportunities, and unmet medical needs You act as the key contact person for allocated... sciences, ideally as a medical doctor or pharmacist You have a minimum of 5-7 years of experience in product and/or portfolio...
, future trends, potential challenges & opportunities, and unmet medical needs You act as the key contact person for allocated... sciences, ideally as a medical doctor or pharmacist You have a minimum of 5-7 years of experience in product and/or portfolio...
Engagement: Work collaboratively with military and civilian personnel, including law enforcement, medical staff, social services..., medical teams, and legal professionals, ensuring comprehensive care and victim support. Mission-Driven Work: Play a key role...
"Caring for People's Health as a Trusted Partner" - Dieser Auftrag motiviert uns bei STADA jeden Tag aufs Neue, die Gesundheit der Menschen weltweit zu verbessern. Mit unserem umfassenden Angebot an Generika, Consumer Health Produkten und S...
, future trends, potential challenges & opportunities, and unmet medical needs You act as the key contact person for allocated... sciences, ideally as a medical doctor or pharmacist You have a minimum of 5-7 years of experience in product and/or portfolio...
individualized safety plans and provide victims with essential resources. Assist victims in navigating medical, legal, and community...: Partner with local organizations, medical personnel, and law enforcement ensuring seamless service delivery. Conduct training...
Ihre Aufgaben Mithilfe bei der Pflege neurologisch erkrankter Patienten Förderung der Therapiemotivation der Patienten Führen der Pflegedokumentation Interdisziplinäre Zusammenarbeit Ihre Qualifikation Abgeschlossene Ausbildung zu...
Luke Littler was throwing darts while still in his nappy. On Friday, the teenager could take the final step of a journey that began almost as soon as he could walk. Continue Reading »
The Nifty PSU Bank index concluded the year with a gain of 14.48%. Among the top performers, State Bank of India (SBI) led with a gain of 23%, followed by Indian Bank with a return of 24% Continue Reading »
Several auto stocks that were once soaring have seen their prices plummet by as much as 50% from their 52-week highs. These drops could present unique investment opportunities for savvy investors, but beware the risks. Continue Reading »
Kotak Mahindra Bank's stock has fallen over 4% in a year, contrasting with an 11% rise in Nifty Bank. Despite this, it gained 19% from its 52-week low and is 6% below its all-time high. Analysts are optimistic about its recovery potential in 2025. Continue Reading »
Despite a drop in its global market share to 4.2% in December 2024, India’s stable macroeconomics have kept its equity market buoyant. .The Nifty50 recorded a 9% return for 2024, though its performance in December was weak compared to other Asian markets. Continue Reading »
Kotak Mahindra Bank shares have rallied more than 6% in four sessions. Foreign brokerage firm Citi initiated a positive catalyst watch on Kotak Mahindra Bank shares expecting stability in loan growth and lower compression in net interest margin (NIM) in the third quarter of FY25. Continue Reading »
Stocks to buy: Analysts anticipate volatility influenced by US interest rates and trade policies. A potential 5-10% correction is expected in early 2025, yet stock-specific opportunities arise, including buy ratings for Varun Beverages, Tata Technologies, and Kalpataru Projects International. Continue Reading »
Sigachi Industries stock rose over 2% after CARE Ratings reaffirmed its credit ratings. The company saw a 38.1% increase in Q2FY25 revenue, with a profit after tax jump of 39%. However, the stock remains down 14% over the past year. Continue Reading »
Sebi's investigation into Ketan Parekh uncovered a front-running scheme that generated ₹65.77 crore in unlawful profits. In an interim order, the regulator debarred Parekh and two others from trading and issued show-cause notices to 22 entities involved, allowing them 21 days to respond. Continue Reading »